Analyst consensus rating
Aethlon Medical Analyst Rating: Hold
AEMD is rated Hold by 2 analysts with a $16.25 target. As of 2026-08-18.
Direct answer
Aethlon Medical's consensus rating is Hold.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.25.
Forecast evidence checked August 18, 2026.
Get free Aethlon Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.87
- Average price target
- $16.25
- High price target
- $25.00
- Low price target
- $7.50
- Low target gap
- +161.2%
- Target upside
- +465.9%
- High target gap
- +770.6%
- Target range width
- 609.4%
- Consensus rating
- Hold
- Analysts
- 2
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Aethlon Medical?
Aethlon Medical has a verified Hold consensus. The same dataset has an average price target of $16.25.
How far are Aethlon Medical's low and high targets from the recorded price?
The low target implies +161.2%, while the high target implies +770.6%.
How many analysts are included in Aethlon Medical's consensus?
The verified consensus includes 2 analysts.
How is Aethlon Medical's target upside or downside calculated?
The average target of $16.25 is divided by the recorded price of $2.87, then one is subtracted to produce +465.9%. This does not guarantee a future return.
When was Aethlon Medical's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.